À retenir
In 465 dementia-free people from the 1946 British birth cohort, each 10 mm Hg higher systolic pressure at age 53 was linked to 7% larger white matter hyperintensity volume (WMHV) on MRI at 69-71 years (95% CI 1-14). Blood pressure did not predict amyloid-β status or cognitive score, and the cohort is observational and one birth year.
Study design
Étude de cohorte
Reading basis
Published abstract
Reading focus
Association & confounding
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Midlife hypertension raises the risk of cognitive impairment later, but the sensitive period for exposure and whether the harm runs through amyloid or vascular damage are poorly understood. The authors asked if, and when, blood pressure or its change across adulthood relates to brain structure, pathology and cognition in late life.
Population et méthode
Analysis within Insight 46, a neuroscience substudy of the Medical Research Council National Survey of Health and Development, a birth cohort of 5362 people born in one week in 1946. Participants aged 69-71 years, all dementia-free, had volumetric MRI, florbetapir amyloid-PET and cognitive testing (Preclinical Alzheimer Cognitive Composite, PACC). Blood pressure had been measured at ages 36, 43, 53, 60-64 and 69, and changes between ages were calculated. Outcomes were WMHV, amyloid-β positivity, whole-brain and hippocampal volume, and PACC. Generalised linear, logistic and linear regression models were adjusted for potential confounders. 502 individuals were assessed between May 28, 2015 and Jan 10, 2018, and 465 were in imaging analyses (238 [51%] men; mean age 70.7 years; 83 [18%] amyloid-β-positive).
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Higher blood pressure at 53 and larger rises between 43 and 53 predicted more white matter damage on MRI at 69-71. Mean WMHV was 7% higher per 10 mm Hg systolic (95% CI 1-14, p = 0.024) and 15% higher per 10 mm Hg diastolic (95% CI 4-27, p = 0.0057).
- 2Per 1 SD change, WMHV was 15% higher for systolic (95% CI 3-29, p = 0.012) and 15% higher for diastolic pressure (95% CI 3-30, p = 0.017).
- 3Higher diastolic pressure at 43 went with smaller whole-brain volume at 69-71 (-6.9 mL per 10 mm Hg, 95% CI -11.9 to -1.9, p = 0.0068), as did larger diastolic rises between 36 and 43 (-6.5 mL per 1 SD, 95% CI -11.1 to -1.9, p = 0.0054).
- 4Larger systolic rises between 36 and 43 went with smaller hippocampal volume (-0.03 mL per 1 SD, 95% CI -0.06 to -0.001, p = 0.043).
- 5Neither absolute blood pressure nor its change predicted amyloid-β status or PACC score.
Limites et incertitude
- 1Only 465 people were analysed, all from a single-age British birth cohort and all dementia-free, so the findings may not generalise to other populations or generations.
- 2Many comparisons across ages and outcomes were made, and some effects are borderline (for example p = 0.043); the hippocampal difference is very small.
- 3The authors found no evidence blood pressure affected cognition or amyloid at this age, so the link to dementia risk itself is not shown here.
- 4As an observational study it cannot prove that lowering blood pressure at around 40 would protect the brain; this reading is based on the abstract only.
Mise en perspective
The study adds support to keeping blood pressure in check from midlife or earlier, since higher and rising pressure was linked to more small-vessel damage and smaller brain volumes decades later. It does not show that treatment at 40 prevents these changes. Blood pressure targets and any treatment decisions belong with your clinician.
Vos données
A home blood pressure cuff is the directly relevant device. Measure at the same time of day, seated and rested, using the same cuff, and look at the average over several readings and across months and years instead of one reading. Share the log with your clinician.
Comprendre ce type de preuve
Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Background
Midlife hypertension confers increased risk for cognitive impairment in late life. The sensitive period for risk exposure and extent that risk is mediated through amyloid or vascular-related mechanisms are poorly understood. We aimed to identify if, and when, blood pressure or change in blood pressure during adulthood were associated with late-life brain structure, pathology, and cognition.
Methods
Participants were from Insight 46, a neuroscience substudy of the ongoing longitudinal Medical Research Council National Survey of Health and Development, a birth cohort that initially comprised 5362 individuals born throughout mainland Britain in one week in 1946. Participants aged 69-71 years received T1 and FLAIR volumetric MRI, florbetapir amyloid-PET imaging, and cognitive assessment at University College London (London, UK); all participants were dementia-free. Blood pressure measurements had been collected at ages 36, 43, 53, 60-64, and 69 years. We also calculated blood pressure change variables between ages. Primary outcome measures were white matter hyperintensity volume (WMHV) quantified from multimodal MRI using an automated method, amyloid-β positivity or negativity using a standardised uptake value ratio approach, whole-brain and hippocampal volumes quantified from 3D-T1 MRI, and a composite cognitive score-the Preclinical Alzheimer Cognitive Composite (PACC). We investigated associations between blood pressure and blood pressure changes at and between 36, 43, 53, 60-64, and 69 years of age with WMHV using generalised linear models with a gamma distribution and log link function, amyloid-β status using logistic regression, whole-brain volume and hippocampal volumes using linear regression, and PACC score using linear regression, with adjustment for potential confounders.
Findings
Between May 28, 2015, and Jan 10, 2018, 502 individuals were assessed as part of Insight 46. 465 participants (238 [51%] men; mean age 70·7 years [SD 0·7]; 83 [18%] amyloid-β-positive) were included in imaging analyses. Higher systolic blood pressure (SBP) and diastolic blood pressure (DBP) at age 53 years and greater increases in SBP and DBP between 43 and 53 years were positively associated with WMHV at 69-71 years of age (increase in mean WMHV per 10 mm Hg greater SBP 7%, 95% CI 1-14, p=0·024; increase in mean WMHV per 10 mm Hg greater DBP 15%, 4-27, p=0·0057; increase in mean WMHV per one SD change in SBP 15%, 3-29, p=0·012; increase in mean WMHV per 1 SD change in DBP 15%, 3-30, p=0·017). Higher DBP at 43 years of age was associated with smaller whole-brain volume at 69-71 years of age (-6·9 mL per 10 mm Hg greater DBP, -11·9 to -1·9, p=0·0068), as were greater increases in DBP between 36 and 43 years of age (-6·5 mL per 1 SD change, -11·1 to -1·9, p=0·0054). Greater increases in SBP between 36 and 43 years of age were associated with smaller hippocampal volumes at 69-71 years of age (-0·03 mL per 1 SD change, -0·06 to -0·001, p=0·043). Neither absolute blood pressure nor change in blood pressure predicted amyloid-β status or PACC score at 69-71 years of age.
Interpretation
High and increasing blood pressure from early adulthood into midlife seems to be associated with increased WMHV and smaller brain volumes at 69-71 years of age. We found no evidence that blood pressure affected cognition or cerebral amyloid-β load at this age. Blood pressure monitoring and interventions might need to start around 40 years of age to maximise late-life brain health.
Funding
Alzheimer's Research UK, Medical Research Council, Dementias Platform UK, Wellcome Trust, Brain Research UK, Wolfson Foundation, Weston Brain Institute, Avid Radiopharmaceuticals.
Sources et attribution
Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study.
Lane CA, Barnes J, Nicholas JM, Sudre CH, Cash DM, Parker TD, Malone IB, Lu K, James SN, Keshavan A, Murray-Smith H, Wong A, Buchanan SM, Keuss SE, Gordon E, Coath W, Barnes A, Dickson J, Modat M, Thomas D, Crutch SJ, Hardy R, Richards M, Fox NC, Schott JM.
The Lancet. Neurology · 2019-08-20
DOI: 10.1016/s1474-4422(19)30228-5 ↗PubMed · 31444142 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people
Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.
Journal of the American Heart Association
Five exercise types lowered resting blood pressure, isometric training the most
Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.
British Journal of Sports Medicine
A salt substitute lowered stroke, major cardiovascular events and death in rural China
In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.
The New England Journal of Medicine
Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation
Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.
The New England Journal of Medicine

